...
机译:Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12.
Department of Adult Oncology, Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. jgollob;
ublic.tpt.tj.cn;
Biological Response Modifiers; CD8-Positive T-Lymphocytes; Interleukin-12; 生物应答调节剂; CD8阳性T淋巴细胞; 白细胞介素12; T淋巴细胞亚群;